PHAROS IBIO
Dead / Abandoned — Abandoned — failure to respond (as of 24 Oct 2024)
What this means for you
This application is over — abandoned 15 Oct 2024. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 79386772
- Mark type
- Design + words
- Filed
- 06 Sept 2023
- Abandoned
- 15 Oct 2024
Goods and services
- Class 005 — Pharmaceuticals: Vaccines; pharmaceutical preparations for the treatment of leukemia; pharmaceutical preparations for the treatment of cells; pharmaceutical preparations and compositions for the treatment and prevention of cancer; biopharmaceuticals for the treatment of cancer; reagents and media for medical and veterinary diagnostic purposes; medicinal healthcare preparations; pharmaceutical drugs; diagnostic agents for pharmaceutical use; medicinal creams; synthetic peptides for pharmaceutical purposes; chemical preparations for pharmaceutical purposes; pharmaceutical compositions; pharmaceuticals; human vaccine preparations; pharmaceutical preparations for tumor treatment; pharmaceutical preparations for the treatment of immune system related diseases and disorders; nutraceuticals for therapeutic purposes; therapeutic drugs and agents; anti-cancer preparations
- Class 042 — Scientific and technological services: Scientific research conducted using databases; research and development of vaccines and medicines; analysis in the field of molecular biology; development of computer software for big data processing; research and development of technology for biotechnology; consultancy in the field of biotechnology; research relating to biotechnology; advisory services relating to biotechnology; biotechnology services; biological information check (genetic testing for scientific research purposes); biological information check (genetic testing for medical research purposes); platform as a service [PaaS]; development of cell therapy products; development, updating and maintenance of software and database systems; drug discovery services; scientific research for medical purposes in the field of cancerous diseases; scientific research for medical purposes in the area of cancerous diseases; consultancy relating to research in the field of pharmacogenetics; research in the field of pharmacogenetics; pharmaceutical research and development; pharmaceutical research services; scientific research in the field of pharmacy; toxicity testing for research purposes; providing technological consultancy relating to design and development of medical diagnostic instruments; providing computer software technical support services in the field of medical diagnostics; medicine research; providing information on the testing, inspection, and research of medical products, consultancy in the field of testing, inspection, and research of medical products; medical and pharmacological research services; scientific research in the fields of medicine, and health and pharmacology; design and development of programs for computers
Owner
Prosecution history
- 11 Sept 2025 — LIMITATION OF GOODS RECEIVED FROM IB
- 20 Jun 2025 — NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
- 03 Jun 2025 — NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
- 03 Jun 2025 — NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
- 24 Oct 2024 — ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
- 24 Oct 2024 — ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
- 01 May 2024 — REFUSAL PROCESSED BY IB
- 11 Apr 2024 — NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
- 11 Apr 2024 — REFUSAL PROCESSED BY MPU
- 23 Mar 2024 — NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
- 22 Mar 2024 — NON-FINAL ACTION WRITTEN
- 18 Mar 2024 — ASSIGNED TO EXAMINER
- 09 Jan 2024 — APPLICATION FILING RECEIPT MAILED
- 05 Jan 2024 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 04 Jan 2024 — SN ASSIGNED FOR SECT 66A APPL FROM IB